Release date: October 15, 2026
Expiration date: October 14, 2029
Estimated Time of Completion: 1 hour and 15 minutes
Session Agenda
- Treating HCV – Review of Guidelines, Collaborative Practice Agreements, and DAAs
Michelle Maguire, PharmD
Samantha Rasure, PharmD
Description
Watch the OH-HEP Training Program, a free, easily accessible training program available to providers across the state. It will meet the needs of both primary care providers interested in providing hepatitis C care and current Ohio Medicaid and private payor requirements. OH-HEP is designed to build (educate and empower) a mentorship platform that is accessible to primary care providers caring for high-risk individuals in every part of Ohio, especially in rural, low resource settings.
Learning Objectives
- Review AASLD/IDSA guidelines for simplified treatment of hepatitis.
- Identify first-line direct acting antiviral medications, dosing, formulations, drug-drug interactions, contraindications and precautions.
- Highlight opportunities to utilize pharmacists and other team members to help patients overcome barriers to accessing and completing treatment.
- Apply AASLD/IDSA guidelines with hepatitis C patient cases and other considerations for prescribing.
Target Audience
The OH-HEP training series is targeted to Ohio-based primary care, infectious disease, gastroenterology, hepatology providers, advanced practice providers (nurses, nurse practitioners, and physician assistants), and pharmacists involved in Hepatitis C treatment or wishing to establish a collaborative practice agreement at their own institution.
Accreditation
Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this internet enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pharmacists / Accreditation Council of Pharmacy Education (ACPE)
Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 1.5 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number List:
Pharmacist: JA0000192-0000-26-416-H01-P
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Erika Harrington, BS
Clinical Pharmacist
Cleveland Clinic
Cleveland, OH
Planning Committee
Walaa Mahmoud, MD
Transplant Hepatology/Hepatology/Gastroenterology
Cleveland Clinic
Cleveland, OH
Samantha Rasure, PharmD
Clinical Pharmacist
Cleveland Clinic
Cleveland, OH
Reviewers
Rebecca Freedman, PharmD
Maria Holztrager, PA
Faculty
Michelle Maguire, PharmD
Ohio Gastroenterology Group, Inc.
Columbus, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias. All relevant financial relationships have been mitigated.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
|
Erika Harrington, BS |
| Abbvie Pharmaceuticals |
Ownership interest (stock, stock options in a publicly owned company) |
| Gilead Sciences, Inc. |
Ownership Interest - Stock (Ended: 12/01/2025)
Ownership interest (stock, stock options in a publicly owned company) (Ended: 12/01/2025)
Teaching and Speaking |
| Michelle Maguire, PharmD |
| Gilead Sciences, Inc. |
Teaching and Speaking |
All other individuals have indicated no relationship which, in the context of their involvement, could be perceived as a potential conflict of interest.
Acknowledgment
Thank you to our online exhibitors - AbbVie Medical Affairs and Gilead Sciences, Inc.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education.
